Amyloid β Oligomer Detection via Thioflavin T Spectral Shifts

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for detecting amyloid β oligomers are either time-consuming, require high-cost reagents, or involve complex experimental procedures, making them inconvenient and expensive.

Innovation Solution

A method using thioflavin T for fluorescence staining, where time-resolved fluorescence spectra are measured and normalized to detect amyloid β oligomers based on specific spectral shifts and ratios, allowing for convenient and cost-effective detection.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If gel electrophoresis and gel filtration chromatography are used to detect Aβ oligomer, then identification of Aβ oligomer can be easily made, but it takes efforts and time for measurement and the distribution of Aβ oligomer cannot be turned into an image

Engineering Contradiction:
Improveidentification accuracyVSAvoidmeasurement time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The patent replaces mechanical separation methods (gel electrophoresis and gel filtration chromatography) with a fluorescence-based detection method using ThT staining and time-resolved fluorescence spectroscopy. This substitution eliminates the need for time-consuming mechanical separation processes while enabling rapid detection and imaging of Aβ oligomer distribution through fluorescence signal analysis.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent utilizes fluorescence color changes of thioflavin T (ThT) when bound to Aβ oligomers. By measuring time-resolved fluorescence spectra and analyzing spectral shifts and intensity ratios, the method enables rapid identification and imaging of Aβ oligomer distribution without requiring mechanical separation, thus reducing measurement time while maintaining identification accuracy.

Inventive Principle:
Principle #32Color changes

2Measurement precision

If antibody-based method is used to detect Aβ oligomer, then detection can be achieved at high sensitivity, but an antibody involving cumbersome and special experimental operations is required and time is also required for the measurement

Engineering Contradiction:
Improvedetection sensitivityVSAvoidexperimental operation simplicity
Core Design Contradiction:
Measurement precisionVSEase of operation

Solution Approach 1:

The patent replaces expensive, specialized antibodies with a inexpensive, readily available fluorescent dye (thioflavin T). This substitution maintains high detection sensitivity through fluorescence signal measurement while dramatically simplifying experimental operations, as ThT staining and fluorescence measurement are routine procedures that do not require specialized antibody handling techniques.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Solution Approach 2:

The patent changes the detection parameter from antibody-antigen binding (which requires specialized reagents and operations) to fluorescence spectral characteristics (which can be measured with standard equipment). By analyzing time-resolved fluorescence spectra and intensity ratios, the method achieves high sensitivity detection with simplified operations, eliminating the need for cumbersome antibody-based procedures.

Inventive Principle:
Principle #35Parameter changes

3Measurement precision

If antibody-based method is used to detect Aβ oligomer, then detection can be achieved at high sensitivity, but it cannot be recognized as a simple and inexpensive measurement method

Engineering Contradiction:
Improvedetection sensitivityVSAvoidmeasurement cost
Core Design Contradiction:
Measurement precisionVSEase of manufacture

Solution Approach 1:

The patent replaces expensive antibodies with an inexpensive fluorescent dye (thioflavin T) that can be purchased at low cost and used without special handling requirements. This substitution maintains high detection sensitivity through fluorescence measurement while dramatically reducing reagent costs, making the measurement method both simple and inexpensive.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Solution Approach 2:

The patent replaces the complex, expensive antibody-based detection system with a simpler fluorescence-based system using ThT staining. This substitution maintains high sensitivity while reducing costs, as fluorescence measurement requires only standard spectroscopy equipment and inexpensive reagents, eliminating the need for costly specialized antibodies and associated handling procedures.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables the detection of amyloid β oligomers with improved convenience and reduced costs, overcoming the limitations of existing methods by utilizing fluorescence staining and spectral analysis.

Implementation Method 1

a method using thioflavin T for fluorescence staining, where time-resolved fluorescence spectra are measured

Methodology Applied
Scientific EffectFluorescence: Fluorescence

Data Source

PatentUS11402328B2Amyloid β oligomer detection method, amyloid β oligomer detection device, and amyloid β oligomer detection program
Publication Date: 2022.08.02 HAMAMATSU PHOTONICS KK
  • US11402328B2 patent drawing
  • US11402328B2 patent drawing
  • US11402328B2 patent drawing

AI summary

The present invention relates to a method for detecting an amyloid β oligomer which includes a test sample and thioflavin T are brought into contact with each other, fluorescence of the thioflavin T is measured to obtain time-resolved fluorescence spectra, the time-resolved fluorescence spectrum of time period t1 to t2 and the time-resolved fluorescence spectrum of time period t3 to t4 are respectively normalized to obtain normalized spectra (t1<t2≤t3<t4), and determination is made to confirm the presence or absence of an amyloid β oligomer in the test sample on the basis of the two normalized spectra, and shifting of the normalized spectrum of time period t3 to t4 towards the low wavelength side in comparison to the normalized spectrum of time period t1 to t2 indicates the presence of an amyloid β oligomer in the test sample.